Geode Capital Management’s Cellectar Biosciences CLRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Sell |
14,439
-428,985
| -97% | -$3.05M | ﹤0.01% | 4053 |
|
|
2025
Q1 | $140K | Buy |
443,424
+92,539
| +26% | +$29.2K | ﹤0.01% | 3941 |
|
|
2024
Q4 | $105K | Sell |
350,885
-1,567
| -0.4% | -$469 | ﹤0.01% | 4087 |
|
|
2024
Q3 | $754K | Buy |
352,452
+11,266
| +3% | +$24.1K | ﹤0.01% | 3457 |
|
|
2024
Q2 | $853K | Buy |
341,186
+25,102
| +8% | +$62.8K | ﹤0.01% | 3371 |
|
|
2024
Q1 | $1.26M | Buy |
316,084
+247,214
| +359% | +$984K | ﹤0.01% | 3274 |
|
|
2023
Q4 | $191K | Buy |
68,870
+6,022
| +10% | +$16.7K | ﹤0.01% | 3957 |
|
|
2023
Q3 | $166K | Buy |
62,848
+15,979
| +34% | +$42.2K | ﹤0.01% | 4052 |
|
|
2023
Q2 | $91.4K | Sell |
46,869
-374
| -0.8% | -$729 | ﹤0.01% | 4364 |
|
|
2023
Q1 | $68K | Sell |
47,243
-784
| -2% | -$1.13K | ﹤0.01% | 4451 |
|
|
2022
Q4 | $82K | Buy |
48,027
+3,588
| +8% | +$6.13K | ﹤0.01% | 4458 |
|
|
2022
Q3 | $149K | Sell |
44,439
-399,976
| -90% | -$1.34M | ﹤0.01% | 4368 |
|
|
2022
Q2 | $179K | Buy |
444,415
+2,532
| +0.6% | +$1.02K | ﹤0.01% | 4338 |
|
|
2022
Q1 | $303K | Hold |
441,883
| – | – | ﹤0.01% | 4179 |
|
|
2021
Q4 | $293K | Hold |
441,883
| – | – | ﹤0.01% | 4301 |
|
|
2021
Q3 | $408K | Buy |
441,883
+44,713
| +11% | +$41.3K | ﹤0.01% | 4130 |
|
|
2021
Q2 | $472K | Buy |
397,170
+152,778
| +63% | +$182K | ﹤0.01% | 3968 |
|
|
2021
Q1 | $393K | Buy |
244,392
+111,997
| +85% | +$180K | ﹤0.01% | 3888 |
|
|
2020
Q4 | $275K | Buy |
+132,395
| New | +$275K | ﹤0.01% | 3788 |
|
|
2018
Q3 | – | Sell |
-72,383
| Closed | -$44K | – | 4127 |
|
|
2018
Q2 | $44K | Buy |
+72,383
| New | +$44K | ﹤0.01% | 3987 |
|
|
2016
Q1 | – | Sell |
-44,858
| Closed | -$33K | – | 4101 |
|
|
2015
Q4 | $33K | Hold |
44,858
| – | – | ﹤0.01% | 4055 |
|
|
2015
Q3 | $88K | Buy |
+44,858
| New | +$88K | ﹤0.01% | 3924 |
|